Chemoradiation therapy is effective for the palliative treatment of malignant dysphagia.

Harvey, J A; Bessell, J R; Beller, E; Thomas, J; Gotley, D C; Burmeister, B H; Walpole, E T; Thomson, D B; Martin, I; Doyle, L; Burmeister, E; Smithers, B M

Harvey, J A; Bessell, J R; Beller, E; Thomas, J; Gotley, D C; Burmeister, B H; Walpole, E T; Thomson, D B; Martin, I; Doyle, L; Burmeister, E; Smithers, B M.

Affiliation

Harvey JA; Combined Upper Gastrointestinal Oncology Clinic, Princess Alexandra Hospital, Woolloongabba, Australia. J.Harvey@mailbox.uq.edu.au

Dis Esophagus ; 17(3): 260-5, 2004.

Article in En | MEDLINE | ID: mdl-15361102

Subject(s)

Antineoplastic Agents/therapeutic use; Deglutition Disorders/therapy; Esophageal Neoplasms/therapy; Fluorouracil/therapeutic use; Palliative Care/methods; Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Cisplatin/therapeutic use; Deglutition Disorders/classification; Deglutition Disorders/etiology; Deglutition Disorders/mortality; Esophageal Neoplasms/complications; Esophageal Neoplasms/mortality; Female; Humans; Male; Middle Aged; Paclitaxel/therapeutic use; Prospective Studies; Radiation Dosage; Radiotherapy, Adjuvant; Stents; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Palliative Care / Esophageal Neoplasms / Deglutition Disorders / Fluorouracil / Antineoplastic Agents Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Language: En Journal: Dis Esophagus Year: 2004 Type: Article Affiliation country: Australia

Search on Google

Add to My VHL

XML

PubMed Links